News

Client News Evonetix wins Best Emerging Synthetic Biology Company at the OBN Awards 12th October 2018 Client News Client News Pharma Integrates 2018: 12–13 November 9th October 2018 Client News Solentim Wins Two Queen’s Awards for Enterprise

Solentim’s business excellence and expertise in cell line development recognised with awards, for both International Trade and Innovation

8th October 2018 Client News Client News Riffyn launches Open Access for scientists at non-profits To celebrate the ground-breaking publication of Riffyn SDE in the journal Scientific Data, Riffyn is launching Open Access which provides free use of the SDE for next-generation design and publishing of experiments 3rd October 2018 Client News Client News Innovate UK Awards Medherant a Medicines Manufacturing Grant New funding to support manufacture of transdermal patches for clinical trials 3rd October 2018 Client News Client News SynbiCITE launches new five-year strategy 2nd October 2018 Client News Client News New study shows how academics are the driving force in oncology R&D Talent pipeline struggling to keep up with demand 2nd October 2018 Client News Client News Major international FDA-led study confirms CellOPTIQ® High Content Assay as leading in vitro platform to assess cardiotoxicity in new drugs 27th September 2018 Client News Domainex appoints Dr Trevor Perrior as Chief Executive Officer 20th September 2018 Client News Client News Identification of synthetic, macrocyclic, orally bioavailable cyclophilin inhibitors with potent HCV activity, published in The Journal of Medicinal Chemistry Discovery follows successful collaboration between Selcia, Cypralis and Gilead Sciences 17th September 2018